{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:22:22Z","timestamp":1791256942020,"version":"4.1.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The myeloproliferative disorder of mice lacking the Src homology 2 (SH2)-containing 5\u2032 phosphoinositol phosphatase, SHIP, underscores the need for closely regulating phosphatidylinositol 3-kinase (PI3K) pathway activity, and hence levels of phosphatidylinositol species during hematopoiesis. The role of the 3\u2032 phosphoinositol phosphatase Pten in this process is less clear, as its absence leads to embryonic lethality. Despite Pten heterozygosity being associated with a lymphoproliferative disorder, we found no evidence of a hematopoietic defect in Pten+\/- mice. Since SHIP shares the same substrate (PIP3) with Pten, we hypothesized that the former might compensate for Pten haploinsufficiency in the marrow. Thus, we examined the effect of Pten heterozygosity in SHIP-\/- mice, predicting that further dysregulation of PIP3 metabolism would exacerbate the pheno-type of the latter. Indeed, compared with SHIP-\/- mice, Pten+\/-SHIP-\/- animals developed a myelodysplastic phenotype characterized by increased hepatosplenomegaly, extramedullary hematopoiesis, anemia, and thrombocytopenia. Consistent with a marrow defect, clonogenic assays demonstrated reductions in committed myeloid and megakaryocytic progenitors in these animals. Providing further evidence of a Pten+\/-SHIP-\/- progenitor abnormality, reconstitution of irradiated mice with marrows from these mice led to a marked defect in short-term repopulation of peripheral blood by donor cells. These studies suggest that the regulation of the levels and\/or ratios of PI3K-derived phosphoinositol species by these 2 phosphatases is critical to normal hematopoiesis. (Blood. 2004;103:4503-4510)<\/jats:p>","DOI":"10.1182\/blood-2003-09-3262","type":"journal-article","created":{"date-parts":[[2004,3,9]],"date-time":"2004-03-09T01:13:44Z","timestamp":1078794824000},"page":"4503-4510","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":30,"title":["Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+\/-SHIP-\/- mice: a novel model of myelodysplasia"],"prefix":"10.1182","volume":"103","author":[{"given":"Jennifer L.","family":"Moody","sequence":"first","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, University of Calgary, AB, Canada; and the Department of Cancer Endocrinology, British Columbia Cancer Agency, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Xu","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, University of Calgary, AB, Canada; and the Department of Cancer Endocrinology, British Columbia Cancer Agency, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl D.","family":"Helgason","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, University of Calgary, AB, Canada; and the Department of Cancer Endocrinology, British Columbia Cancer Agency, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank R.","family":"Jirik","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, University of Calgary, AB, Canada; and the Department of Cancer Endocrinology, British Columbia Cancer Agency, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218415368500_REF1","doi-asserted-by":"crossref","unstructured":"Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2001;17: 615-675.","DOI":"10.1146\/annurev.cellbio.17.1.615"},{"key":"2020021218415368500_REF2","doi-asserted-by":"crossref","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296: 1655-1657.","DOI":"10.1126\/science.296.5573.1655"},{"key":"2020021218415368500_REF3","doi-asserted-by":"crossref","unstructured":"Fruman DA, Cantley LC. Phosphoinositide 3-kinase in immunological systems. Semin Immunol. 2002;14: 7-18.","DOI":"10.1006\/smim.2001.0337"},{"key":"2020021218415368500_REF4","doi-asserted-by":"crossref","unstructured":"Damen JE, Liu L, Rosten P, et al. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci U S A. 1996;93: 1689-1693.","DOI":"10.1073\/pnas.93.4.1689"},{"key":"2020021218415368500_REF5","doi-asserted-by":"crossref","unstructured":"Liu Q, Shalaby F, Jones J, Bouchard D, Dumont DJ. The SH2-containing inositol polyphosphate 5-phosphatase, ship, is expressed during hematopoiesis and spermatogenesis. Blood. 1998;91: 2753-2759.","DOI":"10.1182\/blood.V91.8.2753.2753_2753_2759"},{"key":"2020021218415368500_REF6","doi-asserted-by":"crossref","unstructured":"Luukko K, Ylikorkala A, Tiainen M, Makela TP. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mech Dev. 1999;83: 187-190.","DOI":"10.1016\/S0925-4773(99)00050-7"},{"key":"2020021218415368500_REF7","doi-asserted-by":"crossref","unstructured":"Dowler S, Currie RA, Campbell DG, Deak M, Kular G, Downes CP, Alessi DR. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J. 2000;351: 19-31.","DOI":"10.1042\/bj3510019"},{"key":"2020021218415368500_REF8","doi-asserted-by":"crossref","unstructured":"Marshall AJ, Krahn AK, Ma K, Duronio V, Hou S. TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor. Mol Cell Biol. 2002;22: 5479-5491.","DOI":"10.1128\/MCB.22.15.5479-5491.2002"},{"key":"2020021218415368500_REF9","doi-asserted-by":"crossref","unstructured":"Helgason CD, Damen JE, Rosten P, et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 1998;12: 1610-1620.","DOI":"10.1101\/gad.12.11.1610"},{"key":"2020021218415368500_REF10","doi-asserted-by":"crossref","unstructured":"Liu Q, Sasaki T, Kozieradzki I, et al. SHIP is a negative regulator of growth factor receptor-mediated PKB\/Akt activation and myeloid cell survival. Genes Dev. 1999;13: 786-791.","DOI":"10.1101\/gad.13.7.786"},{"key":"2020021218415368500_REF11","doi-asserted-by":"crossref","unstructured":"Suzuki A, de la Pompa JL, Stambolic V, et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol. 1998;8: 1169-1178.","DOI":"10.1016\/S0960-9822(07)00488-5"},{"key":"2020021218415368500_REF12","doi-asserted-by":"crossref","unstructured":"Podsypanina K, Ellenson LH, Nemes A, et al. Mutation of Pten\/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. 1999;96: 1563-1568.","DOI":"10.1073\/pnas.96.4.1563"},{"key":"2020021218415368500_REF13","doi-asserted-by":"crossref","unstructured":"Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB, Pandolfi PP. Impaired Fas response and autoimmunity in Pten+\/- mice. Science. 1999;285: 2122-2125.","DOI":"10.1126\/science.285.5436.2122"},{"key":"2020021218415368500_REF14","doi-asserted-by":"crossref","unstructured":"Fox JA, Ung K, Tanlimco SG, Jirik FR. Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J Immunol. 2002;169: 49-54.","DOI":"10.4049\/jimmunol.169.1.49"},{"key":"2020021218415368500_REF15","doi-asserted-by":"crossref","unstructured":"Moody JL, Pereira CG, Magil A, Fritzler MJ, Jirik FR. Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice. Genes Immun. 2003;4: 60-66.","DOI":"10.1038\/sj.gene.6363903"},{"key":"2020021218415368500_REF16","doi-asserted-by":"crossref","unstructured":"Jiang X, Stuible M, Chalandon Y, et al. Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. Blood. 2003;102: 2976-2984.","DOI":"10.1182\/blood-2003-05-1550"},{"key":"2020021218415368500_REF17","doi-asserted-by":"crossref","unstructured":"Luo JM, Yoshida H, Komura S, et al. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia. 2003;17: 1-8.","DOI":"10.1038\/sj.leu.2402725"},{"key":"2020021218415368500_REF18","doi-asserted-by":"crossref","unstructured":"Helgason CD, Antonchuk J, Bodner C, Humphries RK. Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice. Blood. 2003;102: 3541-3547.","DOI":"10.1182\/blood-2002-12-3939"},{"key":"2020021218415368500_REF19","doi-asserted-by":"crossref","unstructured":"Kogan SC, Ward JM, Anver MR, et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 2002;100: 238-245.","DOI":"10.1182\/blood.V100.1.238"},{"key":"2020021218415368500_REF20","doi-asserted-by":"crossref","unstructured":"Kalesnikoff J, Sly LM, Hughes MR, et al. The role of SHIP in cytokine-induced signaling. Rev Physiol Biochem Pharmacol. 2003;149: 87-103.","DOI":"10.1007\/s10254-003-0016-y"},{"key":"2020021218415368500_REF21","doi-asserted-by":"crossref","unstructured":"Valderrama-Carvajal H, Cocolakis E, Lacerte A, et al. Activin\/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol. 2002;4: 963-969.","DOI":"10.1038\/ncb885"},{"key":"2020021218415368500_REF22","doi-asserted-by":"crossref","unstructured":"Skorski T, Kanakaraj P, Nieborowska-Skorska M, et al. Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood. 1995;86: 726-736.","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726"},{"key":"2020021218415368500_REF23","doi-asserted-by":"crossref","unstructured":"Sattler M, Verma S, Byrne CH, et al. BCR\/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis. Mol Cell Biol. 1999;19: 7473-7480.","DOI":"10.1128\/MCB.19.11.7473"},{"key":"2020021218415368500_REF24","doi-asserted-by":"crossref","unstructured":"Sattler M, Pride YB, Quinnan LR, et al. Differential expression and signaling of CBL and CBL-B in BCR\/ABL transformed cells. Oncogene. 2002;21: 1423-1433.","DOI":"10.1038\/sj.onc.1205202"},{"key":"2020021218415368500_REF25","doi-asserted-by":"crossref","unstructured":"March ME, Ravichandran K. Regulation of the immune response by SHIP. Semin Immunol. 2002;14: 37-47.","DOI":"10.1006\/smim.2001.0340"},{"key":"2020021218415368500_REF26","doi-asserted-by":"crossref","unstructured":"Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1\/waf1. Science. 2000;287: 1804-1808.","DOI":"10.1126\/science.287.5459.1804"},{"key":"2020021218415368500_REF27","doi-asserted-by":"crossref","unstructured":"Shah AH, Tabayoyong WB, Kimm SY, Kim SJ, Van Parijs L, Lee C. Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease. J Immunol. 2002;169: 3485-3491.","DOI":"10.4049\/jimmunol.169.7.3485"},{"key":"2020021218415368500_REF28","doi-asserted-by":"crossref","unstructured":"Ducos K, Panterne B, Fortunel N, Hatzfeld A, Monier MN, Hatzfeld J. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem\/progenitor cells. J Cell Physiol. 2000;184: 80-85.","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<80::AID-JCP8>3.0.CO;2-Q"},{"key":"2020021218415368500_REF29","doi-asserted-by":"crossref","unstructured":"Pierelli L, Marone M, Bonanno G, et al. Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential. Blood. 2000;95: 3001-3009.","DOI":"10.1182\/blood.V95.10.3001"},{"key":"2020021218415368500_REF30","doi-asserted-by":"crossref","unstructured":"Cheng T, Scadden DT. Cell cycle entry of hematopoietic stem and progenitor cells controlled by distinct cyclin-dependent kinase inhibitors. Int J Hematol. 2002;75: 460-465.","DOI":"10.1007\/BF02982107"},{"key":"2020021218415368500_REF31","doi-asserted-by":"crossref","unstructured":"Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003;17: 590-603.","DOI":"10.1038\/sj.leu.2402824"},{"key":"2020021218415368500_REF32","doi-asserted-by":"crossref","unstructured":"Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410: 50-56.","DOI":"10.1038\/35065016"},{"key":"2020021218415368500_REF33","doi-asserted-by":"crossref","unstructured":"Kim CH, Hangoc G, Cooper S, et al. Altered responsiveness to chemokines due to targeted disruption of SHIP. J Clin Invest. 1999;104: 1751-1759.","DOI":"10.1172\/JCI7310"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4503\/1698327\/zh801204004503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4503\/1698327\/zh801204004503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:40:07Z","timestamp":1581554407000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/12\/4503\/131400\/Anemia-thrombocytopenia-leukocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-09-3262","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]}}}